Understand peptide purity testing: RP-HPLC purity grades, mass spec identity confirmation, and LAL endotoxin assays for rigorous preclinical research standards.
Explore preclinical research on NAD+ DNA repair mechanisms, PARP-1 enzyme activity, and NAD+ depletion in aged animal tissues. Strictly for research contexts.
Explore Melanotan-2 CNS research: MC3R/MC4R expression, neuroprotection in TBI and ischemia models, microglial NF-κB suppression, and oxidative stress data.
Retatrutide triple agonist research: GLP-1R, GIPR, and glucagon receptor mechanisms, Phase 2 NEJM 2023 trial data, and preclinical metabolic comparisons.
Explore preclinical research on Selank and Pinealon neuropeptides: GABA-A modulation, epigenetic neuroprotection, and complementary rodent model findings.
Explore preclinical NAD+ Epithalon longevity research: sirtuin/PARP and telomere pathways, parallel aging hallmarks, and animal-model co-administration data.
Preclinical research on the BPC-157 GHK-Cu stack examines complementary angiogenic, collagen-synthesis, and anti-fibrotic mechanisms in tissue repair models.
Oral BPC-157 dosing protocols in rodent studies: dose ranges in µg/kg, gavage vs drinking water, administration schedules, and endpoint timing reviewed.
Explore oral BPC-157 bioavailability data from rodent preclinical models, covering absorption mechanisms, pharmacokinetics tables, and key research limitations.
Oral BPC-157 tendon repair research: preclinical rat study findings on Achilles tendon transection models, healing rates, and mechanism of action data.